A Need for Basic Research on Fluid-Based Early Detection Biomarkers
Authors:
- 30 June 2010
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (13) , 5203-5206
Abstract
Cancer continues to be a major cause of mortality despite decades of effort and expense. The problem reviewed here is that before many cancers are discovered they have already progressed to become drug resistant or metastatic. Biomarkers found in blood or other body fluids could supplement current clinical indicators to permit earlier detection and thereby reduce cancer mortality. Cancer Res; 70(13); 5203–6. ©2010 AACR.Keywords
This publication has 20 references indexed in Scilit:
- Cancer's Circulation ProblemScience, 2010
- Brawling Over MammographyScience, 2010
- Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung DiseaseCancer Research, 2009
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- Salivary diagnosticsOrthodontics & Craniofacial Research, 2009
- Cancer micrometastasesNature Reviews Clinical Oncology, 2009
- Diagnostic Markers for Ovarian Cancer Screening: Not Ready for Routine Clinical UseClinical Cancer Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- Down-Regulation of the Interferon Signaling Pathway in T Lymphocytes from Patients with Metastatic MelanomaPLOS Medicine, 2007
- Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urineProceedings of the National Academy of Sciences, 2007